Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 314

FunMap reveals a functional network of genes and proteins in human cancer

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in the disease or are innocent bystanders. In a study published in Nature Cancer, researchers at Baylor College of Medicine revealed a powerful and unbiased machine learning-based approach called FunMap for assessing the role of cancer-associated mutations and understudied proteins, with broad implications for advancing cancer biology and informing therapeutic strategies.

“Gaining functional information on the genes and proteins associated with cancer is an important step toward better understanding the disease and identifying potential therapeutic targets,” said corresponding author Dr. Bing Zhang, professor of molecular and human genetics and part of the Lester and Sue Smith Breast Center at Baylor.

“Our approach to gain functional insights into these genes and proteins involved using machine learning to develop a network mapping their functional relationships,” said Zhang, member of Baylor’s Dan L Duncan Comprehensive Cancer Center and a McNair Scholar. “It’s like, I may not know anything about you, but if I know your LinkedIn connections, I can infer what you do.”

A major breakthrough in brain implants

And it’s not from Neuralink.

Recently, Semafor received an extraordinary iMessage. It was from Rodney Gorham, a paralyzed ALS patient, and he had sent it directly from his brain. Gorham has a brain implant called Stentrode. Unlike previous generations of brain-computer interfaces, the Stentrode, from the neurotechnology company Synchron, can be implanted without invasive brain surgery. But… what *are* brain-computer interfaces? How do they work? And where is this novel technology going?

Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology

📝 — Bertran, et al.

Full text is available 👇

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic hepatic disease; nevertheless, no definitive diagnostic method exists yet, apart from invasive liver biopsy, and nor is there a specific approved treatment. Runt-related transcription factor 1 (RUNX1) plays a major role in angiogenesis and inflammation; however, its link with NAFLD is unclear as controversial results have been reported. Thus, the objective of this work was to determine the proteins involved in the molecular mechanisms between RUNX1 and NAFLD, by means of systems biology. First, a mathematical model that simulates NAFLD pathophysiology was generated by analyzing Anaxomics databases and reviewing available scientific literature.

Can We Slow Down Aging? New Biomarker Shows Promise

A research team from the Chinese Academy of Sciences (CAS) and BGI Research has unveiled the complex mechanisms through which immunoglobulins impact the aging process, a discovery that could transform our understanding of aging.

This research, published in Cell on November 4, not only charts a high-precision map of aging across various organs but also reveals the dual-edged sword of immunoglobulins in systemic aging.

The quest for systemic biomarkers and key drivers of aging has been a long-standing puzzle in the field of gerontology. This study, a collaborative effort between Guanghui Liu’s team from the Institute of Zoology (IOZ) of CAS, Ying Gu’s team from BGI Research, Weiqi’s Zhang team from the Beijing Institute of Genomics of CAS, and Jing Qu’s team also from IOZ, has provided compelling answers.

Nano-Switch Discovery: How a Single Hydrogen Atom Powers Life’s Energy Reactions

A new study reveals a ‘nano-switch’ in ferredoxin that affects its electron transfer, which could lead to advancements in sensors and drug development.

Researchers in Japan have discovered a mechanism for controlling the potential of an “electron carrier” protein in the redox reaction that all organisms need to obtain energy. Through experiments, the precise 3D structure of the protein, including hydrogen atoms, was determined, and theoretical calculations using this data visualized the electronic structure of the iron-sulfur cluster.

The results revealed, for the first time, that the electric potential of the iron-sulfur cluster changes dramatically depending on the presence or absence of a single hydrogen atom at an amino acid side chain, a so-called “nano-switch” mechanism. This research, recently published in the journal eLife, not only deepens our scientific understanding of biological reactions but also provides crucial insights for the future development of ultra-sensitive sensors for oxygen and nitric oxide, as well as novel drugs.

Cancer Therapy by Silver Nanoparticles: Fiction or Reality?

As an emerging new class, metal nanoparticles and especially silver nanoparticles hold great potential in the field of cancer biology. Due to cancer-specific targeting, the consequently attenuated side-effects and the massive anti-cancer features render nanoparticle therapeutics desirable platforms for clinically relevant drug development. In this review, we highlight those characteristics of silver nanoparticle-based therapeutic concepts that are unique, exploitable, and achievable, as well as those that represent the critical hurdle in their advancement to clinical utilization. The collection of findings presented here will describe the features that distinguish silver nanoparticles from other anti-cancer agents and display the realistic opportunities and implications in oncotherapeutic innovations to find out whether cancer therapy by silver nanoparticles is fiction or reality.

The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy

Lipids, together with lipoprotein particles, are the cause of atherosclerosis, which is a pathology of the cardiovascular system. In addition, it affects inflammatory processes and affects the vessels and heart. In pharmaceutical answer to this, statins are considered a first-stage treatment method to block cholesterol synthesis. Many times, additional drugs are also used with this method to lower lipid concentrations in order to achieve certain values of low-density lipoprotein (LDL) cholesterol. Recent advances in photodynamic therapy (PDT) as a new cancer treatment have gained the therapy much attention as a minimally invasive and highly selective method. Photodynamic therapy has been proven more effective than chemotherapy, radiotherapy, and immunotherapy alone in numerous studies.